Pharmaceutical

Cipla to bolster OTC portfolio with acquisition of Actor Pharma

Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharma to bolster over-the-counter (OTC) product portfolio.

Sep 5, 2023 - 20:00
Cipla to bolster OTC portfolio with acquisition of Actor Pharma
Cipla Medpro South Africa has signed a binding term sheet to acquire Actor Pharma to bolster over-the-counter (OTC) product portfolio.
Read the original article

Tags:

Previous Article

invIOs’s cell therapy secures Austrian Government grant for Phase Ib trial

Next Article

UK MHRA approves AbbVie’s migraine prevention drug Aquipta

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Teikoku Pharma bags FDA fast track for post-surgical transdermal analgesic  

Teikoku Pharma bags FDA fast track for post-surgical tr...

Jun 21, 2023

STAT+: Large insurers say up to one-quarter of claims run through Change Healthcare

STAT+: Large insurers say up to one-quarter of claims r...

Mar 6, 2024

Ipsen gains global rights to Foreseen Biotech’s FS001 ADC

Ipsen gains global rights to Foreseen Biotech’s FS001 ADC

Jul 14, 2024